Results 161 to 170 of about 16,179 (202)
Some of the next articles are maybe not open access.
Pneumoencephalography of Progressive Supranuclear Palsy
Radiology, 1974Pneumoencephalograms of six patients with progressive supranuclear palsy were analyzed with special attention to the midbrain and were compared to studies of patients with Parkinson's disease and those with various cerebellar degenerative diseases. Severe atrophy of the midbrain tegmentum and atrophy of the superior colliculi relative to the inferior ...
J R, Bentson, J C, Keesey
openaire +2 more sources
The Differentiation of Progressive Supranuclear Palsy
Neurodegenerative Disease Management, 2015The Department of Aged Care, St George & Calvary Hospitals, 3 Chapel Street, Kogarah NSW 2217, Sydney, Australia Neuroscience Research Australia & University of New South Wales, Sydney, Australia *Author for correspondence: Tel.: +612 9113 2183; Fax: +612 9113 3979; Nicholas.Cordato@sesiahs.health.nsw.gov ...
Nicholas J, Cordato, Glenda M, Halliday
openaire +2 more sources
Progressive supranuclear Palsy
Archiv f�r Psychiatrie und Nervenkrankheiten, 1971Es wird uber eine Beobachtung von „progressive supranuclear palsy“ berichtet, bei der die Erkrankung etwa mit 12 Jahren begann, uber 23 Jahre hin langsam progressiv verlief und die klinisch im wesentlichen durch eine parkinsonistische Symptomatik ausgezeichnet war. Anatomisch fand sich neben einer schweren Degeneration der S.
openaire +2 more sources
PROGRESSIVE SUPRANUCLEAR PALSY
Medical Clinics of North America, 1999Richardson observed an unusual clinical syndrome in the 1950s, which he later designated progressive supranuclear palsy (PSP). Over the past 25 years, although knowledge of this disorder has gradually improved, its cause is still unknown, pathogenesis is unclear, and there is still no definitive treatment for this disorder.
openaire +2 more sources
Progressive Supranuclear Palsy
Archives of Neurology, 1973Thirty-one electroencephalograms from 12 patients with progressive supranuclear palsy (PSP) were examined. Four patients had initially abnormal records. Five other patients had initially normal records, but all developed abnormalities during the follow-up period. Three of 12 patients had normal records; each of them had only one record taken.
P C, Su, E S, Goldensohn
openaire +2 more sources
Pain in Progressive Supranuclear Palsy
Clinical Neuropharmacology, 2009We describe a patient with progressive supranuclear palsy who presented with a major complaint of neck pain. The pain was alleviated when given lidocaine intravenously. Response was maintained for an extended period. Lidocaine should be considered in pain relief of dystonia to improve quality of life.
Ilana, Schlesinger +2 more
openaire +2 more sources
Pramipexole in progressive supranuclear palsy
Neurology, 1999Progressive supranuclear palsy (PSP) is a progressive neurodegenerative disorder with no effective treatment. Dopaminergic agents occasionally produce transient symptomatic improvement. The authors report the results of pramipexole treatment (4.5 mg daily) in six patients with PSP (average disease duration, 4.4 years).
W J, Weiner, A, Minagar, L M, Shulman
openaire +2 more sources
Vascular progressive supranuclear palsy
1994Progressive supranuclear palsy (PSP) is a neurologic syndrome of unknown cause. This idiopathic type of PSP is usually associated with characteristic clinical and pathological features.To assess evidence of cerebrovascular disease in a population of patients with clinically defined PSP, and to compare clinical and neuroimaging features in vascular ...
J, Winikates, J, Jankovic
openaire +2 more sources
Progressive supranuclear palsy on Guam
Acta Neuropathologica, 2001This is the first report demonstrating that progressive supranuclear palsy (PSP) exists on Guam. This 75-year-old Guamanian Chamorro patient with slight dementia and rigidity with restriction of ocular up gaze was diagnosed as parkinsonism-dementia complex (PDC) of Guam clinically.
M, Yamazaki +6 more
openaire +2 more sources
Caregiving in progressive supranuclear palsy
Neurology, 1998Basic issues regarding factors influencing progressive supranuclear palsy (PSP) patient caregiver burden remain unresolved, including whether and how disease severity and duration influence caregiver burden.To examine the relation between PSP patient caregiver burden and disease severity, describe the time course of caregiver burden in relation to ...
B, Uttl +3 more
openaire +2 more sources

